Skip to main navigation Skip to search Skip to main content

Myeloproliferativ cancer og kronisk inflammatorisk tarmsygdom

Translated title of the contribution: Myeloproliferative neoplasms and chronic inflammatory bowel disease
  • Heidi Hesselø
  • , Marie Bak
  • , Trine Boysen
  • , Peter Bytzer
  • , Hans Carl Hasselbalch

Abstract

Studies have suggested a possible association between inflammatory bowel disease (IBD) and the Philadelphia-negative chronic myeloproliferative neoplasms (MPNs). The mechanisms behind this association have not been investigated yet, but in this review, we find it most likely to involve complex interactions between genetic, treatment-related and inflammation- and immune-mediated factors. When patients with IBD present with persistent leukocytosis and/or thrombocytosis, it may reflect concomitant MPN, and early detection and treatment of MPNs may prevent some of the complications related to these diseases.

Translated title of the contributionMyeloproliferative neoplasms and chronic inflammatory bowel disease
Original languageDanish
JournalUgeskrift for Laeger
Volume182
Issue number22
ISSN0041-5782
Publication statusPublished - 5 May 2020

Fingerprint

Dive into the research topics of 'Myeloproliferative neoplasms and chronic inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this